Acquired cisplatin resistance in the hea
β
Eva M. Gosepath; Niels Eckstein; Alexandra Hamacher; Kati Servan; Georg von Jonq
π
Article
π
2008
π
John Wiley and Sons
π
French
β 301 KB
π 1 views
## Abstract Head and neck cancers are treated by a combination of surgery, radiotherapy and/or chemotherapy. The clinical success of cisplatinβbased chemotherapy, mostly in combination with 5βFU or a taxane, is however limited by multifactorial intrinsic or acquired resistance. So far, known genes